| Medical-surgical Eye Care, P.a. | |
|
8919 Parallel Parkway, Ste 216, Kansas City, KS 66112 | |
| (913) 299-8800 | |
| (913) 299-6581 |
| Full Name | Medical-surgical Eye Care, P.a. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 8919 Parallel Parkway, Kansas City, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215013206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1411 (Kansas) | Primary |
| Provider Name | Karl Dwight Hendricks |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1174525208 PECOS PAC ID: 9739222654 Enrollment ID: I20100920001173 |
News Archive
A new paper in the February 17th edition of the journal Molecular Cell describes how exposure to low levels of antibiotics increases mutations in E. coli and Staphylococcus bacteria hundreds of times more than normal, making the creation of drug-resistant strains more likely.
To investigate the immune memory sustainability of SARS-CoV-2-specific B cells and T cells, stimulated by the inactivated vaccine, and the potential need for a third booster dose in healthcare workers (HCWs), a non-randomized trial was undertaken by researchers at Sun Yat-sen University in Guangzhou, China. the research is posted online on the medRxiv* preprint server.
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that it has acquired an exclusive world-wide license from Eli Lilly and Company (Lilly) to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist for all human indications.
› Verified 2 days ago
| Provider Name | Brian R Stephens |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1154325025 PECOS PAC ID: 2668597162 Enrollment ID: I20100920001185 |
News Archive
A new paper in the February 17th edition of the journal Molecular Cell describes how exposure to low levels of antibiotics increases mutations in E. coli and Staphylococcus bacteria hundreds of times more than normal, making the creation of drug-resistant strains more likely.
To investigate the immune memory sustainability of SARS-CoV-2-specific B cells and T cells, stimulated by the inactivated vaccine, and the potential need for a third booster dose in healthcare workers (HCWs), a non-randomized trial was undertaken by researchers at Sun Yat-sen University in Guangzhou, China. the research is posted online on the medRxiv* preprint server.
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that it has acquired an exclusive world-wide license from Eli Lilly and Company (Lilly) to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist for all human indications.
› Verified 2 days ago
| Provider Name | Sujote David |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1891797965 PECOS PAC ID: 5799812921 Enrollment ID: I20100920001196 |
News Archive
A new paper in the February 17th edition of the journal Molecular Cell describes how exposure to low levels of antibiotics increases mutations in E. coli and Staphylococcus bacteria hundreds of times more than normal, making the creation of drug-resistant strains more likely.
To investigate the immune memory sustainability of SARS-CoV-2-specific B cells and T cells, stimulated by the inactivated vaccine, and the potential need for a third booster dose in healthcare workers (HCWs), a non-randomized trial was undertaken by researchers at Sun Yat-sen University in Guangzhou, China. the research is posted online on the medRxiv* preprint server.
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that it has acquired an exclusive world-wide license from Eli Lilly and Company (Lilly) to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist for all human indications.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Medical-surgical Eye Care, P.a. 8919 Parallel Parkway, Ste 216, Kansas City, KS 66112 Ph: (913) 299-8800 | Medical-surgical Eye Care, P.a. 8919 Parallel Parkway, Ste 216, Kansas City, KS 66112 Ph: (913) 299-8800 |
News Archive
A new paper in the February 17th edition of the journal Molecular Cell describes how exposure to low levels of antibiotics increases mutations in E. coli and Staphylococcus bacteria hundreds of times more than normal, making the creation of drug-resistant strains more likely.
To investigate the immune memory sustainability of SARS-CoV-2-specific B cells and T cells, stimulated by the inactivated vaccine, and the potential need for a third booster dose in healthcare workers (HCWs), a non-randomized trial was undertaken by researchers at Sun Yat-sen University in Guangzhou, China. the research is posted online on the medRxiv* preprint server.
Dermatologists agree that incidences of black henna reactions are on the rise. Out of the 288 dermatologists who took part in the recent Skin Health Alliance 2017 Dermatologist Survey, 72% thought the incidence of patients with a reaction to black henna temporary tattoos is increasing year on year.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced today that it has acquired an exclusive world-wide license from Eli Lilly and Company (Lilly) to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist for all human indications.
› Verified 2 days ago
Dr. Mark G. Coble, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9501 State Ave, Suite 2, Kansas City, KS 66111 Phone: 913-299-7200 Fax: 913-334-4551 | |
Brian R Stephens, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Ste 226, Kansas City, KS 66112 Phone: 913-299-8800 Fax: 913-299-6581 | |
Michael Sosinski, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3716 State Ave Ste B, Kansas City, KS 66102 Phone: 719-576-1850 | |
Matthew A. Siemer, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 21 N 12th St, Kansas City, KS 66102 Phone: 913-342-4405 | |
Wyandotte Family Eyecare Center, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 21 N 12th St, Kansas City, KS 66102 Phone: 913-342-4405 Fax: 913-342-4406 | |
Karen Suzanne Stephens, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9501 State Ave, Suite 2, Kansas City, KS 66111 Phone: 913-299-7200 Fax: 913-334-4451 |